Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis

BACKGROUND: In investigations of the effectiveness of surgery and adjuvant chemotherapy for gastric cancers, overall survival (OS) is considered the gold standard endpoint. However, the disadvantage of using OS as the endpoint is that it requires an extended follow-up period. We sought to investigat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Oba, Koji, Paoletti, Xavier, Alberts, Steven, Bang, Yung-Jue, Benedetti, Jacqueline, Bleiberg, Harry, Catalano, Paul, Lordick, Florian, Michiels, Stefan, Morita, Satoshi, Ohashi, Yasuo, Pignon, Jean-pierre, Rougier, Philippe, Sasako, Mitsuru, Sakamoto, Junichi, Sargent, Daniel, Shitara, Kohei, Cutsem, Eric Van, Buyse, Marc, Burzykowski, Tomasz
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2013
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4202244/
https://ncbi.nlm.nih.gov/pubmed/24108812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt270
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares